Humana Expects To Lose Enrollees Dually Eligible For Medicare, Medicaid Due To Premium Hike
Main Category: Medicare / Medicaid / SCHIPArticle Date: 15 Sep 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Humana officials on Tuesday said that the company expects membership in Medicare prescription drug plans operated by the company to decrease by almost 10% in 2009 because of a loss of enrollment of dual eligibles, beneficiaries who qualify for Medicare and Medicaid, the Wall Street Journal reports. Medicare covers the full cost of the prescription drug benefit for dual eligibles and automatically enrolls beneficiaries in private plans that submit premium bids less than the average of those received.
In 2009, Humana will lose all 308,000 dual eligibles enrolled in Medicare prescription drug plans operated by the company because the company submitted a premium bid that exceeded the average, according to Humana officials. According to the Journal, "some analysts suggested this might be positive for Humana's bottom line, since higher prices could bolster earnings and these members yield little profit" (Wall Street Journal, 9/10).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/121396.php>
APA
http://www.medicalnewstoday.com/releases/121396.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




